Quest Diagnostics (DGX) Other Non-Current Liabilities (2009 - 2026)

Quest Diagnostics has disclosed Other Non-Current Liabilities across 18 years of filings, most recently posting $1.0 billion for Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $1.0 billion, up 11.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 11.45% YoY), and the FY2025 annual result was $957.0 million, up 2.03% from the prior year.
• Other Non-Current Liabilities came in at $1.0 billion for Q1 2026 at Quest Diagnostics, up from $957.0 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.0 billion in Q1 2026 to a low of $6.0 million in Q2 2024.
• The 5-year median for Other Non-Current Liabilities is $874.0 million (2023), against an average of $772.7 million.
• Across the five-year window, Other Non-Current Liabilities slumped 93.18% in 2024 and soared 14733.33% in 2025, its largest moves.
• Quest Diagnostics' Other Non-Current Liabilities stood at $812.0 million in 2022, then climbed by 7.88% to $876.0 million in 2023, then increased by 7.08% to $938.0 million in 2024, then gained by 2.03% to $957.0 million in 2025, then advanced by 6.79% to $1.0 billion in 2026.
• The last three Other Non-Current Liabilities figures came in at $1.0 billion (Q1 2026), $957.0 million (Q4 2025), and $982.0 million (Q3 2025), per Business Quant data.